Pharmacology

Action Mechanism of Action Reference
AGONIST Insulin receptor agonist

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Insulin Resistance 3 D007333 ClinicalTrials
Coronary Disease 3 D003327 ClinicalTrials
Diabetes Mellitus, Type 1 3 D003922 ClinicalTrials
Hyperglycemia 3 D006943 ClinicalTrials
Diabetes Mellitus 3 D003920 ClinicalTrials
Diabetes Mellitus, Type 2 3 D003924 ClinicalTrials
Diabetes, Gestational 3 D016640 ClinicalTrials
Parkinson Disease 2 D010300 ClinicalTrials
Hyperlipidemias 2 D006949 ClinicalTrials
Pain 2 D010146 ClinicalTrials
Hyperkalemia 2 D006947 ClinicalTrials
Fractures, Bone 2 D050723 ClinicalTrials
Cognitive Dysfunction 2 D060825 ClinicalTrials
Severe Acute Respiratory Syndrome 1 D045169 ClinicalTrials
Wounds and Injuries 1 D014947 ClinicalTrials
Obesity 1 D009765 ClinicalTrials
Multiple Sclerosis, Chronic Progressive 1 D020528 ClinicalTrials
Multiple Sclerosis, Relapsing-Remitting 1 D020529 ClinicalTrials
Carpal Tunnel Syndrome 1 D002349 ClinicalTrials
Delirium 1 D003693 ClinicalTrials
Hyperinsulinism 1 D006946 ClinicalTrials
Hypoglycemia 1 D007003 ClinicalTrials
Ischemic Stroke 1 D000083242 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL1201539
FDA SRS AVT680JB39